DRAP Introduces New Rules for Alternative Medicines in Pakistan
DRAP Sets Licensing Deadlines for Alternative Medicine Manufacturers
DRAP announced the new rules and quality control requirements through a formal memorandum issued on Tuesday. The framework will cover alternative medicines, including vitamins, multivitamins and food supplements.
Under the new regulations, registration and licensing have been made mandatory for manufacturers and sellers of these products. DRAP has given manufacturers six months to obtain licences for producing alternative medicines, while an 18-month deadline has been set for completing their registration.
The authority has also directed manufacturers and sellers of all traditional medicines, including homeopathic products, to comply with the prescribed rules and regulatory requirements.
The memorandum states that approximately 600 manufacturing units are currently producing alternative medicines in Pakistan, while nearly 1,000 importers are involved in bringing such products into the country.
Through the new measures, DRAP aims to strengthen regulatory oversight and ensure that alternative medicines meet established quality and safety standards and are manufactured, imported and sold in accordance with the law.
Comments are closed, but trackbacks and pingbacks are open.